ATSENA
Live / Registered — Registered (as of 27 Feb 2024)
What this means for you
Registered since 27 Feb 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88860854
- Registration number
- 7316506
- Mark type
- Stylized text
- Filed
- 06 Apr 2020
- Published for opposition
- 22 Sept 2020
- Registered
- 27 Feb 2024
- Attorney of record
- Brendan J. Hughes
Goods and services
- Class 005 — Pharmaceuticals: Gene therapy pharmaceutical preparations, namely, adeno-associated virus gene therapies for treatment of ocular disorders
- Class 042 — Scientific and technological services: Scientific research in the field of gene therapies and genetic diseases; scientific research in the field of adeno-associated viruses; development of new technologies for others related to adeno-associated viruses; development of new products for others, namely, development of gene therapy products and pharmaceutical preparations related to adeno-associated viruses
Owner
- Atsena Therapeutics, Inc., Durham, NC, US
- Atsena Therapeutics, Inc., Durham, NC, US
- Atsena Therapeutics, Inc., Durham, NC, US
Prosecution history
- 27 Feb 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Feb 2024 — REGISTERED-PRINCIPAL REGISTER
- 20 Jan 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Jan 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Nov 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 Nov 2023 — NON-FINAL ACTION E-MAILED
- 28 Nov 2023 — SU - NON-FINAL ACTION - WRITTEN
- 28 Nov 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Nov 2023 — USE AMENDMENT FILED
- 17 Nov 2023 — TEAS STATEMENT OF USE RECEIVED
- 20 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 May 2023 — SOU EXTENSION 5 GRANTED
- 16 May 2023 — SOU EXTENSION 5 FILED
- 19 May 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 May 2023 — SOU TEAS EXTENSION RECEIVED